Lung Cancer Immunotherapies Show Promise, But New Directions Needed
Executive Summary
Results from two cancer vaccine studies suggest that lung cancer patients may benefit from immunotherapy, David Carbone (Vanderbilt-Ingram Cancer Center) concluded at the American Society of Clinical Oncology's annual meeting June 4 in Atlanta